Dahl Andrew M.
SVP, Corporate Controller
Dahl Andrew M. has filed 7 SEC Form 4 filings (9 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Sep 14, 2026.
On the most recent filing, Dahl Andrew M. is listed as SVP, Corporate Controller at Edwards Lifesciences Corp. Inside the rolling window, Dahl Andrew M. reported no open-market purchases and 2 open-market sales totaling $98K in EW. The largest disclosed transaction in the window is a sale of 544 EW shares on Aug 31, 2026, worth $50K.
Companies traded
Other insiders at EW
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$98K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Dahl Andrew M. made?
Dahl Andrew M. has filed 7 SEC Form 4 filings (9 transaction rows) across 1 company since 2025.
Which companies does Dahl Andrew M. trade?
Dahl Andrew M. has filed SEC Form 4 disclosures for 1 company, including EW.
When was Dahl Andrew M.'s most recent SEC Form 4 filing?
Dahl Andrew M.'s most recent SEC Form 4 filing on Tracefour is dated Sep 14, 2026.
What is Dahl Andrew M.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Dahl Andrew M. is listed as SVP, Corporate Controller.
What is Dahl Andrew M.'s total buy and sell value in the current window?
Inside the rolling retention window, Dahl Andrew M. bought $0 and sold $98K based on SEC Form 4 filings.
What was Dahl Andrew M.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 544 EW shares on 2026-08-31, worth $50K, per SEC Form 4 filings.